Robert Clarke Selected Research

cysteine-glutathione disulfide

1/2022

Adiposity, metabolomic biomarkers, and risk of nonalcoholic fatty liver disease: a case-cohort study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert Clarke Research Topics

Disease

107	Breast Neoplasms (Breast Cancer) 11/2021 - 01/2002
92	Neoplasms (Cancer) 01/2022 - 01/2002
36	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2002
24	Stroke (Strokes) 01/2022 - 03/2002
23	Coronary Disease (Coronary Heart Disease) 01/2022 - 08/2002
16	Vascular Diseases (Vascular Disease) 01/2021 - 11/2002
12	Inflammation (Inflammations) 01/2020 - 03/2008
11	Cognitive Dysfunction 01/2022 - 07/2003
11	Ischemic Stroke 01/2022 - 05/2012
9	Dementia (Dementias) 04/2009 - 03/2002
8	Hypertension (High Blood Pressure) 01/2020 - 08/2008
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 02/2008
7	Myocardial Infarction 01/2019 - 07/2006
7	Carcinogenesis 10/2016 - 11/2002
6	Obesity 01/2022 - 09/2009
6	Atherosclerosis 01/2019 - 03/2008
6	Type 2 Diabetes Mellitus (MODY) 01/2018 - 02/2008
6	Neoplasm Metastasis (Metastasis) 04/2017 - 01/2004
6	Insulin Resistance 10/2016 - 02/2010
6	Vitamin B 12 Deficiency (Vitamin B12 Deficiency) 03/2011 - 01/2004
5	Necrosis 01/2022 - 01/2010
5	Cerebral Hemorrhage 01/2020 - 01/2018
5	Heart Diseases (Heart Disease) 01/2020 - 05/2005
4	Diabetes Mellitus 01/2021 - 01/2019
4	Alzheimer Disease (Alzheimer's Disease) 09/2019 - 09/2010
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 02/2009
3	Chronic Disease (Chronic Diseases) 10/2021 - 01/2018
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019 - 05/2003
3	Triple Negative Breast Neoplasms 12/2015 - 06/2010
3	Neural Tube Defects (Exencephaly) 07/2014 - 08/2008
2	Embolic Stroke 01/2022 - 12/2019
2	Lacunar Stroke 01/2022 - 01/2019
2	Genetic Risk Score 10/2021 - 01/2020
2	Liver Diseases (Liver Disease) 10/2020 - 10/2018
2	Fibrosis (Cirrhosis) 10/2020 - 10/2018
2	Fatty Liver 10/2020 - 10/2018

Drug/Important Bio-Agent (IBA)

45	Estrogen ReceptorsIBA 11/2021 - 02/2002
30	Estrogen Receptor Modulators (Antiestrogen)IBA 05/2021 - 06/2002
28	Estrogens (Estrogen)FDA Link 01/2020 - 02/2002
26	HomocysteineIBA 01/2019 - 02/2002
23	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2005
23	Tamoxifen FDA LinkGeneric 11/2021 - 10/2003
21	LipidsIBA 01/2022 - 07/2007
19	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022 - 11/2002
17	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2006
17	Biological ProductsIBA 01/2022 - 01/2004
16	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2020 - 07/2003
14	Estrogen Receptor alphaIBA 01/2021 - 02/2002
14	Hormones (Hormone)IBA 01/2019 - 02/2002
13	Pharmaceutical PreparationsIBA 11/2021 - 08/2002
11	CholesterolIBA 01/2019 - 08/2002
11	HDL CholesterolIBA 01/2019 - 07/2007
11	VitaminsIBA 09/2016 - 09/2002
10	Vitamin B Complex (B Vitamins)IBA 08/2011 - 07/2003
9	LDL CholesterolIBA 01/2022 - 08/2002
9	Fulvestrant (Faslodex)FDA Link 06/2014 - 01/2005
8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 07/2007
7	Vitamin D FDA LinkGeneric 05/2021 - 04/2015
7	oxidized low density lipoproteinIBA 01/2020 - 09/2009
7	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 03/2015 - 06/2002
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2010
6	Messenger RNA (mRNA)IBA 01/2020 - 02/2002
6	C-Reactive ProteinIBA 01/2020 - 07/2009
6	Aromatase InhibitorsIBA 01/2019 - 01/2005
6	Lipoprotein(a)IBA 01/2019 - 02/2011
6	Endoplasmic Reticulum Chaperone BiPIBA 02/2017 - 07/2012
6	NF-kappa B (NF-kB)IBA 06/2010 - 10/2003
5	CarcinogensIBA 05/2021 - 12/2005
5	HDL LipoproteinsIBA 01/2020 - 05/2012
5	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2004
4	Transcription Factors (Transcription Factor)IBA 11/2021 - 06/2004
4	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2020 - 11/2002
4	anthraceneIBA 01/2020 - 11/2002
4	Progesterone Receptors (Progesterone Receptor)IBA 01/2019 - 01/2006
4	ApolipoproteinsIBA 01/2019 - 07/2007
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 05/2012
3	ORALIT (ORS)IBA 01/2022 - 01/2018
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 10/2018
3	Triglycerides (Triacylglycerol)IBA 01/2020 - 05/2012
3	SaltsIBA 01/2020 - 03/2007
3	Fibrinogen (Factor I)FDA Link 01/2020 - 10/2012
3	hydroxide ionIBA 12/2019 - 01/2018
3	Amino Acids FDA Link 01/2019 - 11/2018
3	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2018 - 03/2012
3	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2018 - 11/2002
3	Small Interfering RNA (siRNA)IBA 01/2017 - 11/2008
3	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 10/2016 - 06/2012
3	Estradiol (Delestrogen)FDA LinkGeneric 12/2014 - 10/2003
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 06/2012 - 07/2007
3	Lipoproteins (Lipoprotein)IBA 05/2012 - 11/2009
3	Methylmalonic AcidIBA 10/2011 - 05/2005
2	Glutamic Acid (Glutamate)FDA Link 01/2022 - 02/2015
2	InterleukinsIBA 01/2022 - 01/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2019
2	Apolipoproteins B (ApoB)IBA 01/2022 - 09/2009
2	Peptides (Polypeptides)IBA 10/2021 - 01/2021
2	Phosphotransferases (Kinase)IBA 10/2020 - 06/2011
2	Oncogene Proteins (Oncogene Protein)IBA 10/2020 - 10/2014

Therapy/Procedure

46	Therapeutics 01/2020 - 06/2004